Laddar...
HDAC inhibition as a treatment concept to combat temsirolimus-resistant bladder cancer cells
INTRODUCTION: Although the mechanistic target of rapamycin (mTOR) might be a promising molecular target to treat advanced bladder cancer, resistance develops under chronic exposure to an mTOR inhibitor (everolimus, temsirolimus). Based on earlier studies, we proposed that histone deacetylase (HDAC)...
Sparad:
| I publikationen: | Oncotarget |
|---|---|
| Huvudupphovsmän: | , , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Impact Journals LLC
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5746361/ https://ncbi.nlm.nih.gov/pubmed/29299126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.22454 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|